IHC · Independence Holding Co - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 | Q1 '20 | Q4 '19 | Q3 '19 | Q2 '19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.51M | $49.33M | $124.66M | - | $113.22M | $107.31M | $104.00M | - | $95.17M | $95.12M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $21.59M | $32.84M | $50.42M | - | $52.68M | $51.98M | $44.57M | - | $44.35M | $42.21M |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | - | - | $1.12M | - | - | - | $908.0K | - | - | - |
| Operating Income | ($15.08M) | ($704.0K) | $6.86M | - | $10.71M | $737.0K | $5.37M | - | $9.42M | $8.51M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | ($3.57M) | ($267.0K) | $1.29M | - | $1.98M | $199.0K | $1.04M | - | $3.25M | $1.59M |
| Net Income | $17.36M | $76.47M | $5.62M | - | $8.69M | $421.0K | $4.28M | - | $6.14M | $6.85M |
| EPS - Basic | $1.18 | $5.22 | $0.38 | - | $0.59 | $0.03 | $0.29 | - | $0.41 | $0.46 |
| EPS - Diluted | $1.18 | $5.22 | $0.38 | - | $0.59 | $0.03 | $0.29 | - | $0.41 | $0.46 |
Balance Sheet
| Line item | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 | Q1 '20 | Q4 '19 | Q3 '19 | Q2 '19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7.95M | $22.83M | $22.12M | $72.09M | $21.68M | $21.22M | $23.05M | $21.09M | $17.82M | $14.98M |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | - | - | - | - | - | - | - | - | - | - |
| Total Assets | $1.21B | $1.22B | $1.12B | $1.08B | $1.08B | $1.08B | $1.08B | $1.05B | $1.06B | $1.07B |
| Current Liabilities | - | - | - | - | - | - | - | - | - | - |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $641.07M | $668.69M | $648.92M | $611.04M | $609.91M | $619.61M | $617.65M | $592.35M | $587.40M | $600.51M |
| Stockholders' Equity | $564.55M | $548.45M | $473.75M | $469.76M | $467.22M | $459.27M | $459.89M | $459.69M | $473.89M | $468.10M |
| Retained Earnings | $495.50M | $478.14M | $404.89M | $399.27M | $397.00M | $388.32M | $388.10M | $386.86M | $399.16M | $393.02M |
Cash Flow
| Line item | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 | Q1 '20 | Q4 '19 | Q3 '19 | Q2 '19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | $36.53M | - | - | - | $17.83M | - | - | - |
| Investing Cash Flow | - | - | ($83.71M) | - | - | - | ($11.82M) | - | - | - |
| Financing Cash Flow | - | - | ($3.42M) | - | - | - | ($4.48M) | - | - | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 | Q1 '20 | Q4 '19 | Q3 '19 | Q2 '19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | -231.5% | -1.4% | 5.5% | - | 9.5% | 0.7% | 5.2% | - | 9.9% | 8.9% |
| EBITDA margin | - | - | 6.4% | - | - | - | 6.0% | - | - | - |
| Net margin | 266.5% | 155.0% | 4.5% | - | 7.7% | 0.4% | 4.1% | - | 6.5% | 7.2% |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 331.5% | 66.6% | 40.4% | - | 46.5% | 48.4% | 42.9% | - | 46.6% | 44.4% |
| Effective tax rate | -25.9% | -0.4% | 18.7% | - | 18.5% | 32.1% | 19.6% | - | 34.6% | 18.8% |
| Return on assets | 1.4% | 6.3% | 0.5% | - | 0.8% | 0.0% | 0.4% | - | 0.6% | 0.6% |
| Return on equity | 3.1% | 13.9% | 1.2% | - | 1.9% | 0.1% | 0.9% | - | 1.3% | 1.5% |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | - | - | - | - | - | - | - | - | - | - |
| Quick ratio | - | - | - | - | - | - | - | - | - | - |
| Cash ratio | - | - | - | - | - | - | - | - | - | - |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 2.14 | 2.22 | 2.37 | 2.31 | 2.31 | 2.35 | 2.35 | 2.29 | 2.24 | 2.29 |
| Liabilities / Assets | 0.53 | 0.55 | 0.58 | 0.56 | 0.56 | 0.57 | 0.57 | 0.56 | 0.55 | 0.56 |
| Efficiency | ||||||||||
| Asset turnover | 0.01 | 0.04 | 0.11 | - | 0.10 | 0.10 | 0.10 | - | 0.09 | 0.09 |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -94.2% | -54.0% | 19.9% | - | 19.0% | 12.8% | 10.4% | - | 5.8% | 12.1% |
| Revenue CAGR (3y) | -58.3% | -16.6% | 12.2% | - | 10.6% | 9.3% | 13.1% | - | 6.6% | 7.0% |
| Revenue CAGR (5y) | -39.2% | -8.7% | 10.4% | - | -4.2% | -4.2% | -5.0% | - | -6.0% | -6.9% |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | - | - | 27.8% | - | 13.7% | -91.3% | -49.1% | - | -27.0% | -10.4% |
| Net income growth (YoY) | 99.8% | 18064.1% | 31.4% | - | 41.5% | -93.9% | -51.0% | - | -38.2% | 1.3% |
| EPS growth (YoY) | 100.0% | 17300.0% | 31.0% | - | 43.9% | -93.5% | -50.0% | - | -37.9% | 2.2% |
| EPS CAGR (3y) | 21.4% | 126.4% | -6.2% | - | 20.2% | -67.3% | 0.0% | - | 17.9% | 20.9% |
| EPS CAGR (5y) | 36.4% | 82.2% | -42.6% | - | -7.0% | -36.5% | -0.7% | - | 8.7% | 15.9% |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 20.8% | 19.4% | 3.0% | 2.2% | -1.4% | -1.9% | 0.4% | 2.4% | 7.0% | 7.9% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2020-12-31.
Business segments
$442.52M totalSpecialty Health Segment$224.10M · 50.6%
Group Disability Life DBLAnd PFL$214.77M · 48.5%
Individual Life Annuities And Other Segment$2.41M · 0.5%
Corporate$1.24M · 0.3%
Peer comparison
Same SIC group: Life Insurance
Comparing INDEPENDENCE HOLDING CO against the 5 most active filers in the same SIC group.